Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

0.7401

+0.0350 (4.96%)

At close: Aug 12, 2026, 4:00 PM EDT

0.7400

-0.0001 (-0.01%)

After-hours: Aug 12, 2026, 7:34 PM EDT

Estrella Immunopharma Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Operating Income	-13.25	-13.06	-7.31	-11.11
Net Income	-13.25	-13.06	-7.31	-11.11
Earnings Per Share	-0.34	-0.35	-0.27	-36.35
EPS Growth	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2024	FY 2023	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '21 Dec 31, 2021
Cash & Investments	1.93	1.38	0.92	4.17	2.48	45.67
Total Debt	0	0	0	0	0	0
Net Cash (Debt)	1.93	1.38	0.92	4.17	2.48	45.67
Net Cash Growth	357.30%	50.97%	-77.99%	68.02%	-94.57%	-
Net Cash Per Share	0.05	0.04	0.03	0.15	1.75	38.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Operating Cash Flow	-8.02	-1.79	-7.64	-16.07	-1.34
Free Cash Flow	-8.02	-1.79	-7.64	-16.07	-1.34
Free Cash Flow Growth	-	-	-	-	-

Selected indicators aren't available for this stock.